RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs)

Journal of Leukocyte Biology

Volumn 71, Issue 3, 2002, Pages 433-444

  Collison, Kate S ^a   Parhar, Ranjit S ^a   Saleh, Soad S ^a   Meyer, Brian F ^a   Kwaasi, Aaron A ^a   Hammami, Muhammad M ^a   Schmidt, Ann Marie ^b   Stern, David M ^b   Al Mohanna, Futwan A ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b College of Physicians and Surgeons ^*  (United States)

Author keywords

Calcium; Phagocytosis; ROM; Signal; Transmigration

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ALBUMIN; REACTIVE OXYGEN METABOLITE;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DIABETES MELLITUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFECTION SENSITIVITY; NEUTROPHIL; PATHOGENESIS; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING; STAPHYLOCOCCUS AUREUS; VASCULAR DISEASE;

CELL MEMBRANE; CELLS, CULTURED; DIABETIC ANGIOPATHIES; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; NEUTROPHIL ACTIVATION; NEUTROPHILS; RECEPTORS, IMMUNOLOGIC; SERUM ALBUMIN;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 0036521604     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Brownlee, M., Cerami, A., Vlassara, H. (1988) Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic vascular disease. Diabetes Metab. Rev. 4, 437-451.
2. Ruderman, N. B., Williamson, J. R., Brownlee, M. (1992) Glucose and diabetic vascular disease. FASEB J. 6, 2905-2914.
3. Neeper, M., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y. C., Elliston, K., Stern, D., Shaw, A. (1992) Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267, 14998-15004.
4. Wautier, J. L., Zoukourian, C., Chappey, O., Wautier, M. P., Guillausseau, P. J., Cao, R., Hori, O., Stern, D., Schmidt, A. M. (1996) Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. J. Clin. Investig. 97, 238-243.
5. Bucala, R., Makita, Z., Vega, G., Grundy, S., Koschinsky, T., Cerami, A., Vlassara, H. (1994) Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proc. Natl. Acad. Sci. USA 91, 9441-9445.
6. Rosenberg, C. S. (1990) Wound healing in the patient with diabetes mellitus. Nurs. Clin. North Am. 25, 247-261.
7. Mancini, L., Ruotolo, V. (1997) Infection of the diabetic foot. Rays 22, 544-549.
8. Shah, S. V., Wallin, J. D., Eilen, S. D. (1983) Chemiluminescence and superoxide anion production by leukocytes from diabetic patients. J. Clin. Endrocrinol. Metab. 57, 402-409.
9. Sawant, J. K. (1993) Biochemical changes in polymorphonuclear leucocytes in diabetic patients. J. Postgrad. Med. 39, 183-186.
10. Metz, S. A. (1983) Altered arachidonic acid synthesis and lipid peroxidation in diabetes mellitus: possible roles in leukocyte dysfunction and other cellular defects. Med. Hypotheses 12, 341-357.
11. Davidson, N. J., Sowden, J. M., Fletcher, J. (1984) Defective phagocytosis in insulin controlled diabetics: evidence for a reaction between glucose and opsonising proteins. J. Clin. Pathol. 37, 783-786.
12. Cantero, M., Parra, T., Conejo, J. R. (1998) Increased hydrogen peroxide formation in polymorphonuclear leukocytes of IDDM patients. Diabetes Care 21, 326-327.
13. De Toni, S., Piva, E., Lapolla, A., Fontana, G., Fedele, D., Plebani, M. (1997) Respiratory burst of neutrophils in diabetic patients with periodontal disease. Ann. N. Y. Acad. Sci. 15, 363-367.
14. Schmidt, A. M., Vianna, M., Gerlach, M., Brett, J., Ryan, J., Kao, J., Esposito, C., Hegarty, H., Hurley, W., Clauss, M. (1992) Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J. Biol. Chem. 267, 14987-14997.
15. Schmidt, A. M., Yan, S. D., Brett, J., Mora, R., Nowygrod, R., Stern, D. (1993) Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. J. Clin. Investig. 91, 2155-2168.
16. Esposito, C., Gerlach, H., Brett, J., Stern, D., Vlassara, H. (1989) Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J. Exp. Med. 170, 1387-1407.
17. 125I-containing acylating agent. Biochem. J. 133, 529-539.
18. Dunn, J. A., McCance, D. R., Thorpe, S. R., Lyons, T. J., Baynes, J. W. (1991) Age-dependent accumulation of Nε-(carboxymethyl)lysine and Nε-(carboxymethyl)hydroxylysine in human skin collagen. Biochemistry 30, 1205-1210.
19. Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J., Nagashima, M., Nitecki, D., Morser, J., Stem, D., Schmidt, A-M. (1995) The receptor for advanced glycation endproducts (RAGE) is a cellular binding site for amphoterin: mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system. J. Biol. Chem. 270, 25752-25761.
20. Al-Mohanna, F., Parhar, R., Kwaasi, A., Ernst, P., Sheth, K., Harfi, H., Al-Sedairy, S. (1993) Inhibition of neutrophil functions by human immunoglobulin E. J. Allergy Clin. Immunol. 92, 757-766.
21. 2+ and oxidase activation in rat neutrophils. Cell Calcium 9, 17-26.
22. Collison, K. S., Kwaasi, A. A., Parhar, R. S., Al-Sedairy, S. T., Al-Mohanna, F. A. (1995) Monomeric human IgE evokes a transient calcium rise in individual human neutrophils. J. Leukoc. Biol. 58, 459-467.
23. 2+. Biochem. J. 266, 669-674.
24. Edwards, S. W., Hallett, M. B., Lloyd, D., Campbell, A. K. (1983) Decrease in apparent Km for oxygen after stimulation of respiration of rat polymorphonuclear leukocytes. FEBS Lett. 161, 60-64.
25. Campbell, A. K., Hallett, M. B., Weeks, I. (1985) Chemiluminescence as an analytical tool in cell biology and medicine. Methods Biochem. Anal. 31, 317-416.
26. 2+ and tyrosine signaling pathways in human neutrophils. J. Immunol. 161, 3737-3745.
27. 2+ store release in human neutrophils. Cell Biol. Int. 21, 655-663.
28. Brownlee, M. (1995) Advanced protein glycosylation in diabetes and aging. Annu. Rev. Med. 46, 223-234.
29. King, G. L., Brownlee, M. (1996) The cellular and molecular mechanisms of diabetic complications. Endrocrinol. Metab. Clin. North Am. 25, 255-270.
30. Schleicher, E. D., Wagner, E., Nerlich, A. G. (1997) Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J. Clin. Investig. 99, 457-468.
31. Pallinski, W., Koschinsky, T., Butler, S. W., Miller, E., Vlassara, H., Cerami, A., Witztum, J. L. (1995) Immunological evidence for the presence of advanced glycosylation end products in artherosclerotic lesions of euglycemic rabbits. Arterioscler. Thromb. Vasc. Biol. 15, 571-582.
32. Yan, S. D., Yan, S. F., Chen, X., Fu, J., Chen, M., Kuppusamy, P., Smith, M. A., Perry, G., Godman, G. C., Naworth, P. (1995) Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide. Nat. Med. 1, 693-699.
33. Takedo, A., Yasuda, T., Miyata, T., Mizuno, K., Li, M., Yoneyama, S., Horie, K., Maeda, K., Sobue, G. (1996) Immunohistochemical study of advanced glycation end products in aging and Alzheimer's disease brain. Neurosci. Lett. 221, 17-20.
34. Li, Y. M., Mitsuhashi, T., Wojciechowicz, D., Shimizu, N., Li, J., Stitt, A., He, C., Banerjee, D., Vlassara, H. (1996) Molecular identity and cellular distribution of advanced glycation endproduct receptors relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. Proc. Natl. Acad. Sci. USA 93, 11047-11052.
35. Stitt, A. W., Li, Y. M., Bucala, R., Archer, D. B., Vlassara, H. (1997) Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. Am. J. Pathol. 150, 523-531.
36. Vlassara, H., Li, Y. M., Imani, F., Wojciechowicz, D., Yang, Z., Liu, F. T., Cerami, A. (1995) Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex. Mol. Med. 6, 634-646.
37. El Khoury, J., Thomas, C. A., Loike, J. D., Hickman, S. E., Cao, L., Silverstrin, S. C. (1994) Macrophages adhere to glucose-modified basement membrane collagen IV via their scavenger receptors. J. Biol. Chem. 269, 10197-10200.
38. Li, Y. M., Tan, A. X., Vlassara, H. (1995) Antibacterial activity of lysozyme and lactoferrin is inhibited by binding of advanced glycation-modified proteins to a conserved motif. Nat. Med 1, 1057-1061.
39. Thornally, P. J. (1998) Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classsification of AGEs. Cell. Mol. Biol. (Noisy-Le-Grand) 44, 1013-1023.
40. Stitt, A. W., He, C., Vlassara, H. (1999) Characterization of the advanced glycation end-product receptor complex in human vascular endothelial cells. Biochem. Biophys. Res. Commun. 256, 549-556.
41. Schmidt, A. M., Hori, O., Brett, J., Yan, S. D., Wautier, J. L., Stern, D. (1994) Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler. Thromb. 14, 1521-1528.
42. Li, J., Schmidt, A. M. (1997) Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J. Biol. Chem. 272, 16498-16506.
43. Yan, S. D., Stern, D., Schmidt, A. M. (1997) What's the RAGE? The receptor for advanced glycation end products (RAGE) and the dark side of glucose. Eur. J. Clin. Investig. 27, 179-181.
44. Lander, H. L., Taurus, J. M., Ogiste, J. S., Moss, R., Schmidt, A. M. (1997) Activation of the receptor for advanced glycation end products triggers a MAP kinase pathway regulated by oxidative stress. J. Biol. Chem. 272, 17810-17814.
45. Huttunen, H. J., Fages, C., Rauvala, H. (1999) Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-κB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J. Biol. Chem. 274, 19919-19924.
46. Makita, Z., Vlassara, H., Cerami, A., Bucala, R. (1992) Immunochemical detection of advanced glycosylation end products in vivo. J. Biol. Chem. 267, 5133-5138.
47. Vlassara, H., Brownless, M., Cerami, A. (1995) High affinity-receptor mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules. Proc. Natl. Acad. Sci. USA 82, 5588-5592.
48. Kislinger, T., Caifeng, F., Huber, B., Qu, W., Taguchi, A., Yan, S. D., Hoffmann, M., Yan, S. F., Pischetsrieder, M., Stern, D., Schmidt, A. M. (1999) Nε-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J. Biol. Chem. 44, 31740-31749.
49. Pettit, E. J., Hallett, M. B. (1996) Localised and global cytosolic Ca2+ changes in neutrophils during engagement of Cd11b/CD18 integrin visualised using confocal laser scanning reconstruction. J. Cell Sci. 109, 1689-1694.
50. Pettit, E. J., Davies, E. V., Hallett, M. B. (1997) The microanatomy of calcium stores in human neutrophils: relationship of structure to function. Histol. Histopathol. 12, 479-490,
51. Pettit, E. J., Hallett, M. B. (1998) Two distinct Ca2+ storage and release sites in human neutrophils. J. Leukoc. Biol. 63, 225-232.
52. Jin, H., Liu, N. F., Tang, R. (1997) Effects of advanced glycosylation end products on proliferation and cytosolic free calcium in cultured rat aortic smooth muscle cells. Zhongguo Yao Li Xue Bao 18, 422-425.
53. Zhou, Q. G., Liu, N. F., Xie, P. L. (1997) Expression of receptor for advanced glycosylation end products (AGEP) and inhibition of AGEP-induced cytosolic calcium elevation by diltiazem in cultured rat aortic smooth muscle cells. Zhongguo Yao Li Xue Bao 18, 425-430.
54. Rao, K. M., Varani, J. (1982) Actin polymerization induced by chemotactic peptide and concanavalin A in rat neutrophils. J. Immunol. 129, 1605-1607.
55. Howard, T. H., Oresajo, C. O. (1985) The kinetics of chemotactic peptide-induced change in F-actin content, F-actin distribution, and the shape of neutrophils. J. Cell Biol. 101, 1078-1085.
56. Hallett, M. B., Campbell, A. K. (1983) Two distinct mechanisms for stimulation of oxygen-radical production by polymorphonuclear leucocytes. Biochem. J. 216, 459-465.
57. Liu, B. F., Miyata, S., Kojima, H., Uriuhara, A., Kusunoki, H., Suzuki, K., Kusuga, M. (1999) Low phagocytic activity of resident peritoneal macrophages in diabetic mice: relevance to the formation of advanced glycation end products. Diabetes 48, 2074-2082.
58. Millican, S. A., Schultz, D., Bagga, M., Coussons, P. J., Muller, K., Hunt, J. V. (1998) Glucose-modified low density lipoprotein enhances human monocyte chemotaxis. Free Radic. Res. 28, 533-542.
59. Sengoelge, G., Fodinger, M., Skoupy, S., Ferrara, I., Zangerle, C., Rogy, M., Horl, W. H., Sunder-Plassmann, G., Menzel, J. (1998) Endothelial cell adhesion molecule and PMNL response to inflammatory stimuli and AGE-modified fibronectin. Kidney Int. 54, 1637-1651.
60. Van Oss, C. J., Border, J. (1978) Influence of intermittent hyperglycemic glucose levels on the phagocytosis of microorganisms by human granulocytes in vitro. Immunol. Commun. 7, 669-676.
61. Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D., Stern, D. (1994) Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Biol. Chem. 269, 9889-9897.
62. Schmidt, A. M., Hori, O., Chen, J. X., Li, J. F., Crandall, J., Zhang, J., Cao, R., Yan, C. D., Brett, J., Stern, D. (1995) Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vascuolpathy of diabetes. J. Clin. Investig. 96, 1395-1403.